Cargando…
Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes
Marrow stromal cells (MSCs) are in different stages of clinical trials for stroke patients. MSCs are proposed to promote recovery through the release of secretomes that modulate the function of beneficial immune cells. The majority of stroke patients have comorbidities including hypertension, for wh...
Autores principales: | Satani, Nikunj, Giridhar, Kaavya, Cai, Chunyan, Wewior, Natalia, Norris, Dominique D., Aronowski, Jaroslaw, Savitz, Sean I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416264/ https://www.ncbi.nlm.nih.gov/pubmed/32802081 http://dx.doi.org/10.1155/2020/8894168 |
Ejemplares similares
-
A Combination of Atorvastatin and Aspirin Enhances the Pro-Regenerative Interactions of Marrow Stromal Cells and Stroke-Derived Monocytes In Vitro
por: Satani, Nikunj, et al.
Publicado: (2021) -
Peripheral blood monocytes as a therapeutic target for marrow stromal cells in stroke patients
por: Satani, Nikunj, et al.
Publicado: (2022) -
World-Wide Efficacy of Bone Marrow Derived Mesenchymal Stromal Cells in Preclinical Ischemic Stroke Models: Systematic Review and Meta-Analysis
por: Satani, Nikunj, et al.
Publicado: (2019) -
Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model
por: Yang, Bing, et al.
Publicado: (2016) -
Mesenchymal Stem Cell Derived Extracellular Vesicles for Repairing the Neurovascular Unit after Ischemic Stroke
por: Davis, Courtney, et al.
Publicado: (2021)